WASHINGTON, D.C. — As commercial laboratories rapidly extend considerable resources to meet demand for COVID-19 testing, ACLA President Julie Khani sent a letter to congressional leadership seeking support from the federal government.
“We are growing increasingly concerned that the federal government is not recognizing the strain on the laboratory industry to meet the demand for testing for COVID-19,” writes Khani.
As policymakers consider measures to support the public health response to COVID-19, ACLA has asked Congress to support an emergency laboratory surge capacity fund of $5 billion. These funds would help ensure that the clinical laboratory industry has the equipment, supplies, labor and resources necessary to sustain robust testing capacity for millions of Americans.
“Free testing for COVID-19 has now been promised to the American people,” said Khani. “The laboratory industry wholeheartedly supports no-cost testing but is in critical need of additional support from Congress to ensure we have the necessary staffing, supplies and equipment to fulfill that vital promise.”
Highlights from the letter are included below:
To view the full letter, click here
# # #
ACLA is a not-for-profit association representing the nation’s leading clinical and anatomic pathology laboratories, including national, regional, specialty, hospital, ESRD and nursing home laboratories. The clinical laboratory industry employs nearly 295,000 people directly, and generates over 117,000 additional jobs in supplier industries. Clinical laboratories are at the forefront of personalized medicine, driving diagnostic innovation and contributing more than $106 billion to the nation’s economy.